Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII

Peptides

Volumn 21, Issue 4, 2000, Pages 503-508

  Yamamoto, Yukio ^a   Hashimoto, Jun Ichi ^b   Shimamura, Mariko ^a   Yamaguchi, Teruhide ^c   Hazato, Tadahiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

DPPIII; Enkephalin degrading enzymes; Spinorphin; Tynorphin

Indexed keywords

AMINOPEPTIDASE; AMINOPEPTIDASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE; DIPEPTIDYL PEPTIDASE III; ENKEPHALIN DEGRADING ENZYME; ENZYME INHIBITOR; LEUHISITIN; MEMBRANE METALLOENDOPEPTIDASE; SPINORPHIN; SPINORPHIN DERIVATIVE; TYNORPHIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; IC 50; MONKEY; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SERUM; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CATTLE; DIPEPTIDYL PEPTIDASES; DRUG STABILITY; HAPLORHINI; HUMANS; OLIGOPEPTIDES; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034111712     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00174-1     Document Type: Article

References (30)

1. Anderson L., Bussler B., Martins H., Dufton M. Enkephalin-processing oligopeptidases in cobra venom inhibition by thiorphan and bestatin reveals co-operative actions . Toxicon. 36:1998;719-728.
2. Ashmun R.A., Look A.T. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood. 75:1990;462-469.
3. Demchuk E., Bashford D., Case D.A. Dynamics of a typeIV reverse turn in a linear peptide in aqueous solution. Folding Design. 2:1997;35-46.
4. Dickenson A.H. A new approach to pain relief? Nature. 320:1986;681-682.
5. i. Biochem J. 129:1972;197-202.
6. Ellis S., Nuenke J.M. Dipeptidyl arylamidaseIII of the pituitary. Purification and characterization. J Biol Chem. 242:1967;4623-4629.
7. Gorenstein C, Snyder SH. Enkephalinases. Proc R Soc London Ser 1980;B210:123-32.
8. Hayakari M., Kondo Y., Izumi H. A rapid and simple spectrophotometric assay of angiotensin-converting enzymes. Anal Biochem. 84:1978;361-369.
9. Hazato T., Shimamura M., Ichimura A., Katayama T. Purification and characterization of two distinct dipeptidyl aminopeptidases in soluble fraction from monkey brain and their action on enkephalin. J Biochem. 95:1984;1265-1271.
10. Hiddinga H.J., Isaak D.D., Lewis R.V. Enkephalin-containing peptides processed from proenkephalin significantly enhance the antibody-forming cell responses to antigens. J Immunol. 152:1994;3748-3759.
11. Hughes J., Smith T.W., Kosterlitz H.W., Fortergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-580.
12. Iwamoto I., Kimura A., Ochiai K., Tomioka H., Yoshida S. Distribution of neutral endopeptidase activity in human blood leukocytes. J Leukoc Biol. 49:1990;116-125.
13. Iwamoto I., Kimura A., Yamazaki H., Nakagawa N., Tomioka H., Yoshida S. Neutral endopeptidase modulates substance P-induced activation of human neutrophils. Int Arch Allergy Appl Immunol. 93:1990;133-138.
14. Lineweaver H., Burk D. On the determination of enzyme dissociation constants. J Am Chem Soc. 56:1934;658-666.
15. Marksteiner J., Saria A., Kirchmair R., et al. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. Eur J Neurosci. 5:1993;1573-1585.
16. Nishimura K., Hazato T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem Biophys Res Commun. 194:1993;713-719.
17. Nishimura K., Ueki M., Kaneto H., Hazato T. Study of a new endogenous inhibitor of enkephalin-degrading enzymes; pharmacological function and metabolism of spinorphin. Jpn J Anethesiol. 42:1993;1663-1670.
18. Noble F., Smadja C., Valverde O., et al. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical, and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB120. Pain. 73:1997;383-391.
19. Noble F., Soleihac J.M., Soroca-Lucas E., Turcaud S., Fourmie-Zaluski M.C., Roques B.P. Inhibition of enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB101 induces potent analgesic responses in mice and rats. J Pharmacol Exp Ther. 261:1992;181-190.
20. Nyberg F., Sanderson K., Glamsta E-L. The hemorphins a new class of opioid peptides derived from the blood protein hemoglobin . Biopolymers. 43:1997;147-156.
21. Petrov R.V., Mikhailova A.A., Fonina L.A. Bone marrow immunoregulatory peptides (myelopeptides) isolation, structure and functional activity . Biopolymers. 43:1997;139-146.
22. Sanderson K., Andren P.E., Caprioli R.M., Nyberg F. In vitro metabolism of LVV-hemorphin-7 in human plasma studied by reversed-phase high-performance liquid chromatography (HPLC) and micro-electrospray mass spectrometry. J Chromat A. 743:1996;207-212.
23. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10, CALLA, neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration and adhesion proteins and is itself regulated by neutrophil activation. Blood 1991;78:1834-41.
24. Smyth M., O'Cuinn G. Dipeptidyl aminopeptidaseIII of guinea-pig brain specificity for short oligopeptide sequences . J Neurochem. 63:1994;1439-1445.
25. Stefano G.B., Salzet B., Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates immune activation and pain . Immunol Today. 19:1998;265-268.
26. Sudakov SK, Liupina IuV, Medvedeva OF, Tiurina IV, Maldonado R. Characteristics of effects of μ-, δ-, and κ-opioid agonists and enkephalinase inhibitor RB101 in rats of two inbred strains. Biulleten Eksperimentalnoi Biologii I Meditsiny 1998;125:551-4.
27. - generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. Biochem Pharmacol. 54:1997;695-701.
28. Yasothornsrikul S., Aaron W., Toneff T., Hook V.Y. Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex activation by glutatione localized to secretary vesicles . Biochemistry. 38:1999;7421-7430.
29. Wu W.J., Raleigh D.P. Local control of peptide conformation stabilization of cis-proline peptide bonds by aromatic proline interaction . Biopolymers. 45:1998;381-394.
30. Zhao Q., Garreau I., Sannier F., Piot J.M. Opioid peptides derived from hemoglobin hemorphins . Biopolymers. 43:1997;75-98.